Viatris to acquire Pacira BioSciences for $36.50/share in cash in $1.65B deal

Viatris announced a $1.65 billion deal to acquire Pacira BioSciences for $36.50 per share in cash, with the transaction expected to close by the end of 2026.

Detected & updated continuously · Source: Nebula